JPMorgan Chase ( JPM) and Goldman Sachs ( GS ), in leading a loan offering for new AI firm Volta Infrastructure Holdings, are ...
Investors are always following JPMorgan Chase's earnings reports because the bank is a bellwether for the economy.
JPMorgan and Goldman Sachs market a $5B Volta loan at up to 11.75% yield to fund 36,000 Nvidia GPUs for an Anthropic-linked ...
According to The Fly, JPMorgan sees a potential market opportunity of more than $2 billion for Biogen’s felzartamab in ...
Jacob Manoukian, JPMorgan Private Bank U.S. head of investment strategy, joins 'Squawk Box' to discuss the latest market ...
The nation’s biggest banks kick off their third-quarter earnings season early Tuesday when JPMorgan Chase, Goldman Sachs, ...
Enact Holdings ( ACT) stock slipped 1.8% in Monday morning trading after J.P. Morgan downgraded the mortgage insurer's stock ...
JPMorgan’s ambitions come as Europe’s asset management industry is forecast to grow 5.6 per cent a year to reach almost $50tn by 2030, according to a PwC report.
JPMorgan Chase & Co. and Goldman Sachs Group Inc. have taken a rare move to limit their exposure on a $5 billion loan sale ...
Analyst Matt Boss raised his rating on the company to neutral from underweight.
2don MSN
JPMorgan makes bullish call in fixed income space, suggests it's a once in a generation opportunity
Why Priya Misra, a portfolio manager at the firm, is looking to take credit risk in high-quality companies.
Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results